Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 7,767,000 | 7,390,000 | 7,589,000 | 6,829,000 | 6,637,000 |
| Cost of Goods | 3,282,000 | 3,067,000 | 3,282,000 | 2,876,000 | 3,189,000 |
| Gross Profit | 4,485,000 | 4,323,000 | 4,307,000 | 3,953,000 | 3,448,000 |
| Operating Expenses | 3,603,000 | 3,715,000 | 3,656,000 | 3,184,000 | 3,062,000 |
| Operating Income | 882,000 | 608,000 | 651,000 | 769,000 | 386,000 |
| Interest Expense | 210,000 | 227,000 | 246,000 | 218,000 | 214,000 |
| Other Income | 105,000 | 50,000 | 169,000 | 75,000 | 123,000 |
| Pre-tax Income | 777,000 | 431,000 | 574,000 | 626,000 | 295,000 |
| Income Tax | 59,000 | 22,000 | 1,438,000 | 65,000 | 25,000 |
| Net Income Continuous | 718,000 | 409,000 | -864,000 | 561,000 | 270,000 |
| Net Income Discontinuous | 15,000 | 9,000 | 36,000 | 42,000 | 13,000 |
| Net Income | $733,000 | $418,000 | $-828,000 | $603,000 | $283,000 |
| EPS Basic Total Ops | 0.42 | 0.24 | -0.47 | 0.34 | 0.16 |
| EPS Basic Continuous Ops | 0.41 | 0.23 | -0.49 | 0.32 | 0.15 |
| EPS Basic Discontinuous Ops | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 |
| EPS Diluted Total Ops | 0.41 | 0.23 | -0.47 | 0.34 | 0.16 |
| EPS Diluted Continuous Ops | 0.40 | 0.23 | -0.49 | 0.32 | 0.15 |
| EPS Diluted Discontinuous Ops | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 |
| EBITDA(a) | $1,732,000 | $1,492,000 | $1,566,000 | $1,543,000 | $1,464,000 |